Fu's Subcutaneous Needling Versus Filiform Needling for chronic Bell's Palsy : a protocol for a pilot randomized controlled trial
- Conditions
- Chronic Bell's Palsy
- Registration Number
- ITMCTR2200006373
- Lead Sponsor
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Meet the diagnostic criteria for Bells palsy according to Chiese Society of Neurology.
(2) Have had a course of disease of a minimum one month to maximum six months.
(3) Be aged 18-70 years (either sex).
(4) Be absent of facial spasm symptoms.
(5) Voluntarily accept the study protocol and provide written consent.
(1) Are proved to have either an uncontrollable or a diagnosed medical conditions that may impact or disrupt treatment, this includes but is not limited to severe liver, kidney, heart, brain disease. uncontrollable or untreated hypertension (if systolic blood pressure > 160 mmHg and/or diastolic blood pressure > 100 mmHg), uncontrollable or untreated diabetes and hyperthyroidism.
(2) Have allergies to needles and metals.
(3) Show bleeding tendencies such as leukemia and thrombocytopenia.
(4) Show severe or extensive infection and rupture of facial skin tissue.
(5) Refuse to receive FSN or filiform needling therapy.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sunnybrook facial grading system;
- Secondary Outcome Measures
Name Time Method House-Brackmann facial nerve grading system;